Gestational hyperglycemia and gestational diabetes (GDM) are associated with adverse pregnancy outcomes for mothers and newborns. Additionally, GDM, in particular, can also be detrimental to metabolic outcomes later in life. A large genetic study, ?The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study? previously identified a unique genetic association near hexokinase domain component-1 (HKDC1) to gestational hyperglycemia. This study has been confirmed by others and also shown to be associated with GDM. This grant renewal intends to continue our investigation of this important link to gestational glucose metabolism. The focus of this proposal is based on our data that HKDC1 interacts with the mitochondrial outer membrane protein, VDAC, in hepatocytes, where this interaction is disrupted when the amino terminus of HKDC1 is deleted. Further data shows that overexpression of HKDC1 in the liver improved glucose tolerance during pregnancy in mice and our data suggests that this results in a metabolic shift in the carbon flux toward anabolic pathways. Now, it is important to investigate the molecular basis of HKDC1 interaction with mitochondria and the impact of such interactions on mitochondrial morphology and function. Further, we expect that genetic variants contribute to GDM risk via HKDC1 expression, though the specific causal variants remain elusive. In sum, this proposal will mechanistically explore the role of HKDC1 in gestational glucose homeostasis and the genetic variants driving its expression in humans.

Public Health Relevance

Gestational diabetes is a major global health problem. As the incidence of this disease is dramatically increasing worldwide, understanding the pathogenesis of this disease is needed. Because of this, here, we explore, through the variety of cell lines, mouse models, and human tissues, the role of one of the major genetic links to gestational diabetes, HKDC1.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK104927-07
Application #
10119096
Study Section
Integrative Nutrition and Metabolic Processes Study Section (INMP)
Program Officer
Teff, Karen L
Project Start
2015-09-21
Project End
2025-07-31
Budget Start
2020-09-11
Budget End
2021-07-31
Support Year
7
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Illinois at Chicago
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
098987217
City
Chicago
State
IL
Country
United States
Zip Code
60612
Priyadarshini, Medha; Kotlo, Kumar U; Dudeja, Pradeep K et al. (2018) Role of Short Chain Fatty Acid Receptors in Intestinal Physiology and Pathophysiology. Compr Physiol 8:1091-1115
Yamamoto, Soh; Kuramoto, Kenta; Wang, Nan et al. (2018) Autophagy Differentially Regulates Insulin Production and Insulin Sensitivity. Cell Rep 23:3286-3299
Khan, Md Wasim; Ding, Xianzhong; Cotler, Scott J et al. (2018) Studies on the Tissue Localization of HKDC1, a Putative Novel Fifth Hexokinase, in Humans. J Histochem Cytochem 66:385-392
Dugas, Lara R; Bernabé, Beatriz Peñalver; Priyadarshini, Medha et al. (2018) Decreased microbial co-occurrence network stability and SCFA receptor level correlates with obesity in African-origin women. Sci Rep 8:17135
Villa, Stephanie R; Mishra, Rama K; Zapater, Joseph L et al. (2017) Homology modeling of FFA2 identifies novel agonists that potentiate insulin secretion. J Investig Med 65:1116-1124
Layden, Brian T; Wicksteed, Barton; Mauvais-Jarvis, Franck (2017) Incretin-Based Therapies: Revisiting Their Mode of Action. Endocrinology 158:1560-1563
Ludvik, Anton E; Pusec, Carolina M; Priyadarshini, Medha et al. (2016) HKDC1 Is a Novel Hexokinase Involved in Whole-Body Glucose Use. Endocrinology 157:3452-61
Levine, Joshua A; Kaihara, Kelly A; Layden, Brian T et al. (2016) Long-term activation of PKA in ?-cells provides sustained improvement to glucose control, insulin sensitivity and body weight. Islets 8:125-34
Priyadarshini, Medha; Wicksteed, Barton; Schiltz, Gary E et al. (2016) SCFA Receptors in Pancreatic ? Cells: Novel Diabetes Targets? Trends Endocrinol Metab 27:653-664
Villa, Stephanie R; Priyadarshini, Medha; Fuller, Miles H et al. (2016) Loss of Free Fatty Acid Receptor 2 leads to impaired islet mass and beta cell survival. Sci Rep 6:28159